Moderna to make milestone payments to NIH for COVID vaccine
(Reuters) – Moderna Inc will make certain contingent development, commercial and regulatory milestone payments to the U.S. National Institutes of Health (NIH) related to the development of COVID-19 vaccines, the company said in a filing on Friday. Moderna and the U.S. government agency had entered into a license agreement in December related to certain patents …
Moderna to make milestone payments to NIH for COVID vaccine Read More »